Skip to main content

Atrion Corporation Announces Election of New Director

Written by Customer Service on . Posted in Public Companies.

ALLEN, Texas, Aug. 30, 2021 (GLOBE NEWSWIRE) — Atrion Corporation (NASDAQ: ATRI) today announced the election of Maria Sainz as a director, effective immediately.

Ms. Sainz brings to our Board over 20 years of medical device and management experience from both Silicon Valley start-ups and large medical device companies. During the period from 2008 until early this year, she served as the CEO of three innovative medtech start-ups. One of these companies was acquired by CooperSurgical in 2021 and another was acquired by Stryker Corporation in 2011. At Stryker, she led the Business Unit that comprised her former company. From 1998 to 2006, Ms. Sainz held a number of leadership positions at Guidant Corporation, including President of the Cardiac Surgery division, Vice President, Global Marketing for the Vascular Intervention division, and Vice President of the Intermedics Cardiac Rhythm Management business in Europe. From 2006 to 2008, Ms. Sainz led integration activities following the acquisition of Guidant by Boston Scientific.

Ms. Sainz serves as a director of two other public companies, ShockWave Medical (SWAV) and Avanos Medical (AVNS). We are proud to add Ms. Sainz to our Board.

Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.

Contact:Jeffery Strickland
 Vice President and Chief Financial Officer
 (972) 390-9800

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.